ArticleOpen forum infectious diseases2020

Artificial Intelligence Platform Demonstrates High Adherence in Patients Receiving Fixed-Dose Ledipasvir and Sofosbuvir: A Pilot Study.

Alain H Litwin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.